| Identification | Back Directory | [Name]
Z-TLE-OH DCHA | [CAS]
62965-37-1 | [Synonyms]
Z-TLE-OH DCHA
Z-TLE-OH DHCA
Cbz-L-Tle·DCHA
Z-L-Tle-OH·DCHA
CBZ-Tle-OH·DCHA
Z-TBU-GLY-OH DCHA
Z-TBU-GLYCINE DCHA
Z-TLE-OH DCHA USP/EP/BP
N-CBZ-L-leucineDCHA-salt
Z-a-tert-butyl-Gly-OH·DCHA
Z-L-tert-butyl-Gly-OH·DCHA
Z-ALPHA-T-BUTYL-GLY-OH DCHA
Z-Tle-OH dicyclohexylamine salt
Cbz-t-leucine dicyclohexylaMine salt
Z-Tle-OH (dicyclohexylammonium) salt
Cbz-L-Tert-LeucineDicyclohexylamineSalt
Z-L-TERT-LEUCINE DICYCLOHEXYLAMINE SALT
CBZ-L-TERT-LEUCINE DICYCLOHEXYLAMMONIUM SALT
Z-L-tert-butyl-glycine dicyclohexylamine salt
Z-L-tert-Leucine (dicyclohexylammonium) salt
N-Benzyloxycarbonyl-L-tert-leucine dicyclohexylamine salt
N-ALPHA-CARBOBENZOXY-L-TERT-LEUCINE DICYCLOHEXYLAMINE SALT
(-)-N-BENZYLOXYCARBONYL-L-TERT-LEUCINE DICYCLOHEXYLAMMONIUM SALT
N-ALPHA-CARBOBENZOXY-L-ALPHA-T-BUTYLGLYCINE DICYCLOHEXYLAMINE SALT
Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)-amino)-3,3-dimethylbutanoate
(-)-N-Benzyloxycarbonyl-L-tert-leucine dicyclohexyl ammonium salt for synthesis
3-Methyl-N-[(phenylmethoxy)carbonyl]-L-valine compd. with N-cyclohexylcyclohexanamine
N-cyclohexylcyclohexanamine,(2S)-3,3-dimethyl-2-(phenylmethoxycarbonylamino)butanoicaci
N-cyclohexylcyclohexanamine,(2S)-3,3-dimethyl-2-(phenylmethoxycarbonylamino)butanoic acid
L-Valine, 3-methyl-N-(phenylmethoxy)carbonyl-, compd. with N-cyclohexylcyclohexanamine (1:1) | [EINECS(EC#)]
478-250-9 | [Molecular Formula]
C14H19NO4.C12H23N | [MDL Number]
MFCD00161480 | [MOL File]
62965-37-1.mol | [Molecular Weight]
446.63 |
| Chemical Properties | Back Directory | [Melting point ]
163-167 °C | [density ]
1.1 at 20℃ | [vapor pressure ]
0Pa at 25℃ | [storage temp. ]
2-8°C | [form ]
Solid | [PH]
6.3 (H2O, 20℃)(saturated solution) | [optical activity]
[α]20/D 6.5±1°, c = 1% in methanol | [BRN ]
3831936 | [LogP]
1.6 at 25℃ and pH2.5 | [Surface tension]
63mN/m at 1g/L and 20℃ |
| Hazard Information | Back Directory | [Uses]
3-methyl-N-[(phenylmethoxy)carbonyl]-L-Valine, with N-cyclohexylcyclohexanamine is used in the preparation of an intermediate towards the interleukin-1β converting enzyme inhibitor VX-765 using the palladium-catalyzed coupling of a bromodihydrofuranone with Cbz-L-prolinamide as the key step. | [reaction suitability]
reaction type: solution phase peptide synthesis |
|
|